Business Context and Reporting Period
This Form 6-K filing by UBS Group AG and UBS AG, dated July 28, 2015, discloses the consolidated BIS Basel III leverage ratio information as of June 30, 2015. The disclosure is mandated by the revised FINMA Circular 2008/22 and Swiss regulations effective January 1, 2015, requiring quarterly reporting of leverage ratios.
Key Financial Metrics
The filing focuses exclusively on regulatory capital and exposure metrics rather than standard GAAP/IFRS profitability or cash flow.
- BIS Basel III Leverage Ratio (Phase-in): 4.3%
- BIS Basel III Leverage Ratio (Fully Applied): 3.6%
- Total Exposures (Leverage Ratio Denominator) - Phase-in: CHF 954.0 billion
- Total Exposures (Leverage Ratio Denominator) - Fully Applied: CHF 949.3 billion
- Tier 1 Capital (Phase-in): CHF 40.6 billion
- Tier 1 Capital (Fully Applied): CHF 34.0 billion
- IFRS Total Assets: CHF 950.2 billion
Material Changes and Composition
The filing details the reconciliation between IFRS total assets and the regulatory leverage ratio denominator. Significant adjustments include:
- Derivatives: Carrying values of derivative financial instruments (CHF 198.6 billion) and securities financing transactions (CHF 105.2 billion) are deducted from IFRS assets and recalculated as exposure measures.
- Regulatory Scope: Adjustments were made for investments in banking and financial entities consolidated for accounting purposes but excluded from regulatory consolidation (CHF 17.5 billion).
- Exposure Breakdown: Total derivative exposures amounted to CHF 157.0 billion, while securities financing transaction exposures totaled CHF 132.0 billion.
The filing does not provide comparative data for the prior period (e.g., March 31, 2015) within this specific document; it refers investors to the second quarter 2015 report for movement analysis.
Guidance, Outlook, and Risks
This document contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the regulatory context. It explicitly states that the information is for disclosure purposes only and is not a solicitation to buy or sell securities. Investors are directed to the UBS Group Basel III Pillar 3 First Half 2015 Report (expected by end of August 2015) for further details on regulatory scope and movements.
Investor Verification Checklist
- Verify the full Q2 2015 earnings report for revenue, profit, and cash flow data not included in this filing.
- Review the upcoming UBS Group Basel III Pillar 3 First Half 2015 Report for detailed analysis of leverage ratio movements.
- Confirm the distinction between "phase-in" and "fully applied" leverage ratios to understand the impact of transitional regulatory rules.
- Check the reconciliation of IFRS assets to regulatory exposures to assess the magnitude of off-balance sheet items and derivatives.